Cytokine/Antibody Fusion Protein Design and Evaluation

Area of Science:

• Biotechnology
• Immunology
• Protein Engineering

Background:

• Cytokines are crucial for immune regulation but face clinical limitations due to off-target effects and short half-lives.
• Engineering cytokines into fusion proteins, specifically immunocytokines, offers a strategy to enhance therapeutic properties.
• Intramolecular assembly of immunocytokines biases signaling and improves pharmacological profiles.

Purpose of the Study:

• To provide a detailed workflow for designing, producing, and validating intramolecularly assembled immunocytokines.
• To address challenges in producing immunocytokines, such as preventing aggregation.
• To demonstrate a modular approach applicable to various cytokines for biomedical applications.

Main Methods:

• Gene manipulation for creating immunocytokine constructs.
• Mammalian cell-based expression and purification of fusion proteins.
• Bio-layer interferometry for binding analysis and assembly validation.
• Functional assays on human primary cells to assess signaling activity.

Main Results:

• A comprehensive protocol for generating and validating intramolecular immunocytokines.
• Demonstration of successful design, production, and purification of functional immunocytokines.
• Validation of binding kinetics and specific cytokine signaling modulation.

Conclusions:

• Intramolecularly assembled immunocytokines represent a promising therapeutic strategy.
• The presented workflow facilitates the development of engineered cytokines with improved efficacy and safety.
• This modular platform can be adapted for diverse cytokine-based therapeutic development.